Shan Dong Kexing Bioproducts Co (SHSE:688136) Accounts Payable & Accrued Expense : ¥220 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Shan Dong Kexing Bioproducts Co Accounts Payable & Accrued Expense?

Shan Dong Kexing Bioproducts Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥242 Mil) to Dec. 2023 (¥243 Mil) but then declined from Dec. 2023 (¥243 Mil) to Mar. 2024 (¥220 Mil).

Shan Dong Kexing Bioproducts Co's annual accounts payable & accrued expense declined from Dec. 2021 (¥283 Mil) to Dec. 2022 (¥279 Mil) and declined from Dec. 2022 (¥279 Mil) to Dec. 2023 (¥243 Mil).

Shan Dong Kexing Bioproducts Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shan Dong Kexing Bioproducts Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shan Dong Kexing Bioproducts Co Accounts Payable & Accrued Expense Chart

Shan Dong Kexing Bioproducts Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

185.79

208.04

282.91

278.55

243.27

Shan Dong Kexing Bioproducts Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															188.05	216.43	242.20	243.27	219.93

Shan Dong Kexing Bioproducts Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shan Dong Kexing Bioproducts Co (SHSE:688136) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shan Dong Kexing Bioproducts Co Ltd (SHSE:688136) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Shandong Province, Jinan, CHN, 250200

Website

http://www.kexing.com

Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.

Executives

Wang Xiao Qin	Directors, senior managers
Cui Ning	Directors, senior managers
Ma Hong Jie	senior management
Shao Ke	senior management
Deng Xue Qin	Director
Zhao Yan Qing	Directors, senior managers

Shan Dong Kexing Bioproducts Co (SHSE:688136) Headlines

No Headlines